Influence of dietary protein and recombinant porcine somatotropin administration in young pigs: II. Accretion rates of protein, collagen, and fat.
The present study was conducted to determine the effects of different dietary protein levels and recombinant porcine somatotropin (rpST) administration on deposition rates of protein, fat, water, ash, and collagen in pigs. Ten groups of six barrows (30 kg BW) were restrictively fed (80% of ad libitum) one of five diets containing 11, 15, 19, 23, or 27% CP. Diets were isoenergetic and all contained equivalent amounts of lysine. Thirty barrows were treated daily with rpST (100 micrograms/kg) by i.m. injection; remaining pigs were treated with diluent for 42 d. At all levels of dietary protein intake, carcass and empty body accretion rates of protein, water, and ash were greater in rpST-treated pigs than in respective controls. The magnitude of change elicited by rpST was lowest in pigs consuming 11% CP. Administration of rpST resulted in a 34% decrease in the accretion rate of fat; increasing protein intake resulted in a linear decrease in fat accretion in control and rpST-treated pigs. Accretion rates of protein, water, ash, and fat were increased in viscera of rpST-treated pigs compared with respective controls; rates of visceral protein and water accretion were increased as dietary protein was increased, whereas deposition of fat was decreased in control and rpST-treated pigs. Administration of rpST resulted in an overall 66% increase in the utilization efficiency of dietary protein for empty body protein deposition. Protein intake had minimal effect on the concentration of collagen in the carcass; however, rpST treatment increased concentrations of total and soluble collagen by 30 and 33%, respectively. Recombinant pST had little influence on collagen crosslinking or maturation. Deposition rate of carcass collagen was increased 63% in rpST-treated pigs compared with respective controls.
Caperna
T J
TJ
US Department of Agriculture, Beltsville, MD 20705.
Komarek
D R
DR
Gavelek
D
D
Steele
N C
NC
D000273:Adipose Tissue / Q000254:growth & development; D000818:Animals; D001823:Body Composition / Q000187:drug effects*; D001834:Body Water / Q000378:metabolism; D003094:Collagen / Q000378:metabolism; D004044:Dietary Proteins / Q000008:administration & dosage* / Q000378:metabolism; D013006:Growth Hormone / Q000494:pharmacology*; D050356:Lipid Metabolism; D008297:Male; D011506:Proteins / Q000378:metabolism; D011994:Recombinant Proteins / Q000494:pharmacology; D013552:Swine / Q000254:growth & development*; D014781:Viscera / Q000378:metabolism
D004044:Dietary Proteins; D011506:Proteins; D011994:Recombinant Proteins; D013006:Growth Hormone; D003094:Collagen